SYNTHIA Trademark

Trademark Overview


On Thursday, March 8, 2018, a trademark application was filed for SYNTHIA with the United States Patent and Trademark Office. The USPTO has given the SYNTHIA trademark a serial number of 87825579. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, August 21, 2024. This trademark is owned by Merck KGaA. The SYNTHIA trademark is filed in the Communication Services, Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Electronic databases in the fields of drug development and drug manufacturing, recorded on computer media; bioinformatics software for storing, indexing, searching, retrieving, and accessing information about biological data for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, and drug discovery, drug development, and drug manufacturing; chemoinformatics software for storing, indexing, searching, retrieving, and accessing information about chemical compounds and chemical data for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; software for use in biological and chemical modelling, analysis and information management for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility o...

Providing access to databases for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy

Licensing of computer software used for retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy

Biotechnology and pharmaceutical research relating to retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, and drug development; professional consultancy in relation to drug development; scientific research and development for others; scientific research in the nature of analysis and preparation of data relating to retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery and drug development; provision of information in relation to drug discovery and drug development; provision of scientific information related to pharmacy; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy
synthia

General Information


Serial Number87825579
Word MarkSYNTHIA
Filing DateThursday, March 8, 2018
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, August 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 24, 2024

Trademark Statements


Goods and ServicesElectronic databases in the fields of drug development and drug manufacturing, recorded on computer media; bioinformatics software for storing, indexing, searching, retrieving, and accessing information about biological data for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, and drug discovery, drug development, and drug manufacturing; chemoinformatics software for storing, indexing, searching, retrieving, and accessing information about chemical compounds and chemical data for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; software for use in biological and chemical modelling, analysis and information management for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; software for computer-aided molecular design, data processing and data analysis for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; chemical data analysis software for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; drug discovery information systems software used to solve problems in connection with chemical syntheses for use in the field of organic chemistry; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy
Goods and ServicesProviding access to databases for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy
Goods and ServicesLicensing of computer software used for retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy
Goods and ServicesBiotechnology and pharmaceutical research relating to retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, and drug development; professional consultancy in relation to drug development; scientific research and development for others; scientific research in the nature of analysis and preparation of data relating to retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery and drug development; provision of information in relation to drug discovery and drug development; provision of scientific information related to pharmacy; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy

Classification Information


International Class038 - Services allowing people to communicate with another by a sensory means.
US Class Codes100, 101, 104
Class Status Code6 - Active
Class Status DateWednesday, March 14, 2018
Primary Code038
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateWednesday, March 14, 2018
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 14, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 14, 2018
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMerck KGaA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDarmstadt 64293
DE

Trademark Events


Event DateEvent Description
Wednesday, April 4, 2018NON-FINAL ACTION WRITTEN
Monday, March 12, 2018NEW APPLICATION ENTERED
Wednesday, March 14, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 27, 2018ASSIGNED TO EXAMINER
Wednesday, April 4, 2018NON-FINAL ACTION E-MAILED
Wednesday, April 4, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 2, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 2, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 2, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 8, 2018NON-FINAL ACTION WRITTEN
Thursday, November 8, 2018NON-FINAL ACTION E-MAILED
Thursday, November 8, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 11, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 11, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 12, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 19, 2019SUSPENSION LETTER WRITTEN
Tuesday, March 19, 2019LETTER OF SUSPENSION E-MAILED
Tuesday, March 19, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, May 9, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, May 16, 2019ASSIGNED TO LIE
Monday, May 20, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 20, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 10, 2019SUSPENSION LETTER WRITTEN
Monday, June 10, 2019LETTER OF SUSPENSION E-MAILED
Monday, June 10, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, December 20, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, June 22, 2020ASSIGNED TO LIE
Tuesday, June 23, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Saturday, June 26, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, August 23, 2021NON-FINAL ACTION WRITTEN
Monday, August 23, 2021NON-FINAL ACTION E-MAILED
Monday, August 23, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 3, 2021ASSIGNED TO EXAMINER
Monday, February 21, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 21, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 21, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 28, 2022SUSPENSION LETTER WRITTEN
Thursday, April 28, 2022LETTER OF SUSPENSION E-MAILED
Thursday, April 28, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, November 30, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, February 14, 2023ASSIGNED TO EXAMINER
Thursday, March 2, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, March 3, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, October 11, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, October 11, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, April 12, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, April 15, 2024SUSPENSION INQUIRY WRITTEN
Monday, April 15, 2024INQUIRY TO SUSPENSION E-MAILED
Monday, April 15, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Saturday, July 13, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, July 13, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, July 13, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, August 13, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 15, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, September 4, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED